rs2402970 — NRF1

NRF1 rs2402970 — The Aerobic Baseline Variant

Nuclear respiratory factor 1 (NRF1) is the master transcription factor that executes the mitochondrial biogenesis program — converting the upstream signal from PGC-1alpha into actual transcription of the nuclear genes that build the electron transport chain, import proteins into the mitochondrion, and replicate mitochondrial DNA. NRF1 binds directly to the promoters of TFAM, cytochrome c, and all five respiratory complex subunit genes, making it the essential link between the cell's energy-sensing machinery and the physical manufacture of new mitochondria.

The rs2402970 polymorphism lies within an intron of NRF1 on chromosome 7 at position 129,739,961 (GRCh38 plus strand). The C allele is the major allele globally (~83%) and is associated with higher baseline aerobic efficiency. The T allele is the minor allele (~17% globally; ~12% in Europeans, ~27% in Africans), and is associated with lower ventilatory threshold and poorer running economy at baseline — before any training intervention. This distinguishes rs2402970 from the companion NRF1 variant rs6949152: rs6949152 primarily predicts training response (how much your aerobic capacity improves with endurance training), while rs2402970 predicts baseline aerobic function (where you start from). Together they describe two distinct facets of NRF1 activity in aerobic physiology.

The Mechanism

rs2402970 is an intronic variant with no protein-coding consequence. Its molecular mechanism has not been directly characterized, but intronic variants at positions embedded deep within large introns — as this one is (c.1348+12596C>T per Ensembl annotation) — can influence pre-mRNA splicing efficiency, regulatory element occupancy, or RNA secondary structure in ways that alter mature transcript levels. Consistent with a transcriptional-output effect, the phenotypic pattern in exercise studies is a graded baseline difference across genotypes rather than a binary loss of function.

NRF1's downstream targets explain why a subtle reduction in its transcriptional output manifests as reduced aerobic efficiency specifically: TFAM (the mitochondrial transcription factor A) determines mitochondrial genome copy number; cytochrome c is the electron shuttle between complexes III and IV; and the nuclear-encoded subunits of complexes I–V set the ceiling for oxidative phosphorylation capacity. A T-allele-driven reduction in NRF1 activity would compress the entire downstream cascade, resulting in fewer mitochondria and slightly less efficient oxidative phosphorylation per unit of muscle mass — manifesting as a lower ventilatory threshold and higher metabolic cost at any given running speed.

The Evidence

The primary evidence comes from He et al.¹¹ He et al.
He Z et al. NRF-1 genotypes and endurance exercise capacity in young Chinese men. Br J Sports Med, 2008, a prospective 18-week endurance training RCT in 102 young Han Chinese male soldiers (mean age 19). Three NRF1 polymorphisms were genotyped: rs2402970, rs6949152, and rs10500120. For rs2402970, a significant genotype effect was seen for ventilatory threshold (VT, p = 0.004) and running economy (RE at 12 km/h, p = 0.027) at baseline — before any training began. These are baseline phenotype differences, not training-response interactions, meaning the genotype predicts the starting aerobic efficiency of individuals rather than how much they improve with exercise. The effect size at p = 0.004 is notably stronger than the rs6949152 signal (p = 0.047 for its training-response interaction), suggesting rs2402970 tags a functional regulatory element with a more direct effect on NRF1 output.

A secondary line of evidence comes from Taherzadeh-Fard et al.²² Taherzadeh-Fard et al.
Taherzadeh-Fard E et al. PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Molecular Neurodegeneration, 2011, which genotyped 15 NRF1 SNPs in more than 400 German Huntington disease patients. NRF1 variants — including rs2402970 — showed nominally significant associations with age of onset of HD motor symptoms. Because HD age of onset is partly determined by how well neurons maintain mitochondrial energy production under the toxic polyglutamine stress of mutant huntingtin, this finding independently supports the hypothesis that NRF1 transcriptional output (influenced by rs2402970) modulates mitochondrial resilience in neuronal tissue — consistent with the aerobic muscle findings but extending to brain energy homeostasis.

A 2024 neuronal study³³ 2024 neuronal study
Massaro M et al. Nuclear respiratory factor-1 (NRF1) induction drives mitochondrial biogenesis and attenuates amyloid beta-induced mitochondrial dysfunction and neurotoxicity. Neurotherapeutics, 2024 showed that increasing NRF1 expression in neurons under amyloid-beta stress restored mitochondrial mass, improved ATP synthesis, and reduced ROS — reinforcing that even modest variation in NRF1 activity level has functional consequences in post-mitotic cells with high and continuous energy demands.

The Williams et al. 2017 systematic review⁴⁴ Williams et al. 2017 systematic review
Williams CJ et al. Genes to predict VO2max trainability: a systematic review. BMC Genomics, 2017 identified rs2402970 among candidate variants for aerobic capacity, noting limited independent replication — consistent with the moderate evidence grade assigned here.

Practical Actions

The T allele's association with lower baseline ventilatory threshold and running economy points to interventions that support NRF1 transcriptional output and compensate for reduced baseline mitochondrial density. Unlike rs6949152, where the primary deficit is blunted aerobic adaptation, rs2402970 T-carriers start from a lower aerobic baseline — which affects both endurance performance and the metabolic milieu of skeletal muscle at rest. Lower VT means the muscle shifts to anaerobic metabolism at lower exercise intensities, and poorer running economy means more oxygen is consumed for the same mechanical output.

Mitophagy activators (urolithin A) address mitochondrial quality; NAD+ precursors (NMN or NR) activate the SIRT1/PGC-1alpha pathway that coactivates NRF1; HIIT-style training provides the strongest stimulus for AMPK-driven NRF1 upregulation. For T/T homozygotes, all three approaches in combination are warranted.

Interactions

The closest interaction is with the companion NRF1 variant rs6949152. Both SNPs are intronic in NRF1 and were studied together by He et al. 2008 in the same cohort. rs2402970 predicts baseline aerobic efficiency (VT, running economy), while rs6949152 predicts training-response magnitude (VT gain over 18 weeks). A person carrying T at rs2402970 and G at rs6949152 would start with a lower aerobic baseline and also have a blunted training response — a compound disadvantage in the NRF1 biogenesis axis.

The interaction with PPARGC1A rs8192678 (Gly482Ser) operates one step upstream: the Ser482 allele impairs PGC-1alpha's ability to coactivate NRF1 and MEF2 transcription factors. When PPARGC1A Ser482 reduces the upstream coactivation signal and rs2402970 T independently reduces NRF1 baseline output, the two deficits stack at different points in the same mitochondrial biogenesis cascade.

FOXO3 rs2802292 is a secondary interaction partner through mitochondrial quality control: the FOXO3 G allele enhances mitophagy and stress resilience, partially compensating for reduced NRF1-driven biogenesis. Absence of the protective FOXO3 G allele in a T-carrier at rs2402970 leaves both mitochondrial quantity and quality under-supported.